Lunit
328130.KQKorean cancer-diagnostics AI company: Lunit INSIGHT for chest X-ray and mammography and Lunit SCOPE for tissue-slide biomarkers, sold to hospitals and biopharma; listed on KOSDAQ.
Products
Selected offerings — the AI products recorded here, not the vendor's full catalogue.
-
Lunit INSIGHT CXR Application
AI chest X-ray analysis software that flags findings for radiologists; part of the Lunit INSIGHT line alongside mammography and tomosynthesis products.
-
Lunit SCOPE Application
AI precision-oncology software for tissue slides: Lunit SCOPE IO (immuno-oncology) and the SCOPE IHC suite (HER2, PD-L1, uIHC), for biopharma and pathology labs.
Inside Lunit SCOPE IHC Suite
-
Lunit SCOPE PD-L1 detects and classifies PD-L1 biomarker expression in digitized IHC whole-slide images.
Similar products 25
No sourced competitor yet: no filing, vendor document or measured-market report read so far names a rival for this company, so none is asserted. The companies below are the closest by what their products do.
Closest alternatives are pairs a vendor page itself compares. Similar products are matched from what each product does; nothing in that group is asserted as a rivalry.
Sources
- Total funding
-
Listed company; no funding rounds stated.
- Market cap
-
The investor page's market cap did not load; no figure recorded.
- Founded
-
Pages read for this record state no founding year.
- Public listing
-
Company disclosure · 13 Oct 2026
Investor page: "Stock Info Lunit 328130 ... KOSDAQ".
- Description
-
Official documentation · 13 Oct 2026
Homepage navigation: Lunit INSIGHT CXR, Lunit SCOPE IO, SCOPE IHC suite, SCOPE HER2, SCOPE PD-L1.
Something wrong here? Send a correction — quote this company id: lunit.